| 1 |
Gui D, Dong Z, Peng W, Jiang W, Huang G, Liu G, Ye Z, Wang Y, Xu Z, Fu J, Luo S, Zhao Y. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation. Cancer Med 2021;10:3674-88. [PMID: 33973730 DOI: 10.1002/cam4.3911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Liu H, Yang Y. Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma. Front Mol Biosci 2021;8:719982. [PMID: 34646862 DOI: 10.3389/fmolb.2021.719982] [Reference Citation Analysis]
|
| 3 |
Otto T. Surgical resection should be viewed with skepticism in patients with bladder cancer. Dtsch Arztebl Int 2013;110:176. [PMID: 23533552 DOI: 10.3238/arztebl.2013.0176a] [Reference Citation Analysis]
|
| 4 |
Patel V, Collazo Lorduy A, Stern A, Fahmy O, Pinotti R, Galsky MD, Gakis G. Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Bladder Cancer 2017;3:121-32. [PMID: 28516157 DOI: 10.3233/BLC-170108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 5 |
Faltas BM, Gennarelli RL, Elkin E, Nguyen DP, Hu J, Tagawa ST. Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes. Urol Oncol 2018;36:9.e11-7. [PMID: 28988653 DOI: 10.1016/j.urolonc.2017.09.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 6 |
Heidenreich A. In reply. Dtsch Arztebl Int 2013;110:176. [PMID: 23533553 DOI: 10.3238/arztebl.2013.0176b] [Reference Citation Analysis]
|
| 7 |
Hu J, Zheng Z, Zheng J, Xie W, Su H, Yang J, Xu Z, Shen Z, Yu H, Fan X, Kong J, Han J. A Model for Identifying Optimal Patients for Primary Tumor Resection in Patients With Metastatic Bladder Cancer. Front Oncol 2022;11:809664. [DOI: 10.3389/fonc.2021.809664] [Reference Citation Analysis]
|
| 8 |
Serra F, Guidetti C, Spatafora F, Cabry F, Farinetti A, Mattioli Anna V, Gelmini R. Case report: Acute hepatic failure secondary to metastatic LIVER'S infiltration by upper tract urothelial carcinoma. Ann Med Surg (Lond) 2019;45:66-9. [PMID: 31388417 DOI: 10.1016/j.amsu.2019.07.019] [Reference Citation Analysis]
|
| 9 |
Fattahi Masoum SH, Feizzdeh Kerigh B, Goreifi A. Pulmonary and chest wall metastasectomy in urogenital tumors: a single center experience and review of literature. Nephrourol Mon 2014;6:e17258. [PMID: 25032142 DOI: 10.5812/numonthly.17258] [Reference Citation Analysis]
|
| 10 |
Abufaraj M, Dalbagni G, Daneshmand S, Horenblas S, Kamat AM, Kanzaki R, Zlotta AR, Shariat SF. The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review. Eur Urol 2018;73:543-57. [PMID: 29122377 DOI: 10.1016/j.eururo.2017.09.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 11 |
Roos FC, Thüroff JW. [Resecting hematogenous metastases: reasons against]. Urologe A 2014;53:817-22. [PMID: 24824465 DOI: 10.1007/s00120-014-3467-7] [Reference Citation Analysis]
|
